Debbie Anaby1, Maria Raitses-Gurevich2, Sara Apter1,3, Yael Inbar1,3, Hadassa Degani4, and Talia Golan2,3
1Diagnostic Imaging Department, Sheba Medical Center, Ramat Gan, Israel, 2Department of Oncology, Sheba Medical Center, Ramat Gan, Israel, 3Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 4Life Sciences, Weizmann Institute of Science, Rehovot, Israel
1Diagnostic Imaging Department, Sheba Medical Center, Ramat Gan, Israel, 2Department of Oncology, Sheba Medical Center, Ramat Gan, Israel, 3Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 4Life Sciences, Weizmann Institute of Science, Rehovot, Israel
DT-MRI was utilized in pancreatic
pathologies and healthy controls. A reduction of the fast diffusing component
is observed in pancreatic tumor regions as compared to healthy or cystic
pancreatic tissue. Therefore, DT-MRI may be of help in the identification of
pancreatic malignancy.
